Ph III Trial Shows Improved Outcomes with Tremfya after Failure With Humira

Ph III Trial Shows Improved Outcomes with Tremfya after Failure With Humira

Submitted by admin on September 12, 2018 - 11:08am
Source: 
CP Wire
News Tags: 
Janssen Pharmaceuticals
JNJ
chronic plaque psoriasis
Tremfya
Humira
AbbVie
clinical trials
Headline: 
Ph III Trial Shows Improved Outcomes with Tremfya after Failure With Humira
snippet: 
  • Switching to Tremfya at week 28 after inadequate response to Humira, led to a sustained improvement
  • Tremfya is a human monoclonal antibody

Do Not Allow Advertisers to Use My Personal information